Antibiotic side effects

Seminars in Respiratory and Critical Care Medicine

Volumn 21, Issue 1, 2000, Pages 53-60

  Gleckman, Richard A ^a   Czachor, John S ^b  

^a ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; Drug drug interactions; Respiratory tract infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZTREONAM; CEFAMANDOLE; CEFDINIR; CEFIXIME; CEFONICID; CEFOPERAZONE; CEFOTETAN; CEFTIBUTEN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CISPLATIN; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; DOXYCYCLINE; ETACRYNIC ACID; LATAMOXEF; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BLEEDING; COLITIS; DIARRHEA; ELDERLY CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPROTHROMBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LIVER TOXICITY; PHLEBITIS; PNEUMOCYSTIS PNEUMONIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 0034022321     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9928     Document Type: Review

References (43)

1. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-1607
2. Saliba B, Herbert PN. Oxacillin hepatotoxicity in HIV-infected patients. Ann Intern Med 1994;120:1048
3. Coopman SA, Johnson RA, Platt R, et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993;328:1670-1674
4. Lin RY. A perspective on penicillin allergy. Arch Intern Med 1992;152:930-937
5. Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med 1984;101:92-104
6. Titanji R, Trofa A. Hypokalemia associated with ticarcillin-clavulanic acid. Maryland Med J 1993;42:1013-1014
7. Sattler FR, Weitekamp MR, Ballard JO. Potential for bleeding with the new beta-lactam antibiotics. Ann Intern Med 1986; 105:924-931
8. Linton AL, Clark WF, Driedger AA, et al. Acute enterstitial nephritis due to drugs. Ann Intern Med 1980;93:735-741
9. Pass RJ, Copelan EA, Brandt JT, et al. Platelet-medicated bleeding caused by broad-spectrum penicillins. J Infect Dis 1987;155:1242-1248
10. Heim-Duthoy KL, Caperton EM, Pollack R, et al. Apparent biliary pseudolithiasis during ceftriaxone therapy. Antimicrob Agents Chemother 1990;34:1146-1149
11. Calandra G, Lydick E, Carrigan J, et al. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin. Am J Med 1988;84:911-918
12. Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis: A prospective study. Ann Intern Med 1974;81: 429-433
13. Joshi N, Miller DQ. Doxycycline revisited. Arch Intern Med 1997;157:1421-1428
14. Wallace MR, Mascolo JR, Oldfield EC. Red man syndrome: Incidence, etiology and prophylaxis. J Infect Dis 1991; 164:1180-1185
15. Appel GB. Aminoglycoside nephrotoxicity. Am J Med 1990;88 (suppl 3C):16S-20S
16. Jick H. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 1982;4:426-428
17. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991;91(suppl A)75:40S-45S
18. Stahlmann R, Lode H. Safety overview: Toxicity, adverse effects and drug interactions. In: Andriole VT, ed. The Quinolones. San Diego: Academic Press, 1998;369-414
19. Watkins VS, Polk RE, Stotka JL. Drug interactions of macrolides: Emphasis on dirithromycin. Ann Pharmacother 1997;31:349-356
20. Anderson JA. Allergic reactions to drugs and biological agents. JAMA 1992;268:2845-2858
21. Pleasants RA, Walker TR, Samuelson WM. Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis. Chest 1994;106:1124-1128
22. Segreti J, Trenholme GM, Levin S. Antibiotic therapy in the allergic patient. Med Clin North Am 1995;79:935-942
23. Itokazu GS, Weinstein RA. Aerosolized antimicrobials: Another look. Crit Care Med 1998;26:5-6
24. Manian FA, Stone WJ, Alford RH. Adverse antibiotic effects associated with renal insufficiency. Rev Infect Dis 1990; 12:236-249
25. Livornese LL Jr, Benz RL, Ingerman MJ, et al. Antibacterial agents in renal failure. Infect Dis Clin North Am 1995; 9:591-614
26. Kroboth PD, McNeil MA, Kreeger A, et al. Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysis. Arch Intern Med 1983;143:1263-1265
27. McCormack JP, Jewesson PJ. A critical re-evaluation of the "therapeutic range" of aminoglycosides. Clin Infect Dis 1992;14:320-339
28. Hatala R, Dinh T, Cook DJ. One daily aminoglycoside dosing in immunocompetent adults: A meta-analysis. Ann Intern Med 1996;124:717-725
29. Barza M, Ioannidis JP, Cappeleri JC, et al. Single or multiple daily doses of aminoglyccosides: A meta-analyses. BMJ 1996;312:338-345
30. Prins JM, Weverling GJ, de Blok K, et al. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 1996;40:2494-2499
31. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31
32. Glyptis A, Sordillo EM, Kotler DP. The Cockcroft Gault (CG) equation is inaccurate for prediction of creatinine clearance (CrC1): A caution for aminoglycoside dosing. Clin Infect Dis 1996;23:915(Abstract 297)
33. Hichling K, Begg EJ, Perry RE, et al. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients. Crit Care Med 1991;19:1041-1047
34. Sands M, Brown RB. Interactions of cyclosporine with antimicrobial agents. Rev Infect Dis 1989;11:691-696
35. Paterson DL, Singh N. Interactions between tacrolimus and antimicrobial agents. Clin Infect Dis 1997;25:1430-1440
36. Bradley PP, Warden GD, Maxwell JG, et al. Neutropenia and thrombocytopenia in renal allograft recipients treated with trimethoprim-sulfamethoxazole. Ann Intern Med 1980;93: 560-562
37. Korzeniowski O. Antibacterial agents in pregnancy. Infect Dis Clin North Am 1995;9:639-651
38. Helms SE, Bredle DL, Zajic J, et al. Oral contraceptive failure rates and oral antibiotics. J Am Acad Dermatol 1997; 36:705-710
39. Gleckman R. Antibiotic concerns in the elderly: A clinician's perspective. Infect Dis Clin North Am 1995;9:575-590
40. Millan J, Gleckman R. Selecting the right antibiotics for elderly patients. J Crit Illness 1997;12:590-598
41. Gleckman RA, Borrego F. Adverse reactions to antibiotics: Clues for recognizing, understanding, and avoiding them. Postgrad Med 1997;101:97-108
42. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: A summary. MMWR Morb Mortal Wkly Rep 1995;44:1-35
43. Carr A, Penny R, Cooper DA. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. AIDS 1993;7:65-71